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Serum from 2 Norwegians with tickborne encephalitis
(TBE) (1 of whom was infected in Denmark) and 810
Norwegian ticks were tested for TBE virus (TBEV) RNA by
reverse transcription–polymerase chain reaction.
Sequencing and phylogenetic analysis were performed.
This is the first genome detection of TBEV in serum from
Norwegian patients.
T
ickborne encephalitis (TBE) is a viral zoonotic disease
caused by TBE flavivirus (TBEV). Three subtypes of
TBEV have been reported: the European (TBEV-Eu) sub-
type, transmitted by Ixodes ricinus ticks and widely dis-
tributed in Europe, and the Siberian (TBEV-Sib) and
Far-Eastern (TBEV-FE) subtypes, carried by I. persulcatus
ticks and present from the Far-East to Baltic countries (1).
TBE is endemic in Scandinavia along the coastal areas of
the Baltic Sea. The first reports of TBE from Sweden,
Finland, and Denmark date back to 1954, 1956, and 1963,
respectively. The disease was not diagnosed in Norway
until 1997 (2). Since then, 11 serologically confirmed
cases of indigenous human TBE have been reported. A
related flavivirus has been isolated in Norway from sheep;
it was subsequently analyzed as louping ill virus (LIV), not
TBEV (3).
In neighboring Denmark, 14 human TBE cases on
Bornholm Island were reported and serologically con-
firmed from 1994 to 2002 (4). Recently, both TBEV and
LIV have been detected in ticks from Bornholm by reverse
transcription–polymerase chain reaction (RT-PCR),
although these viruses have not been further characterized
genetically (5). Antibody tests suggest that human disease
in Norway and Denmark is caused by TBEV, but virus has
not been isolated from humans in these countries. The aim
of this study was to identify and genetically characterize
TBEV from Norway.
The Study
Serum collected before the appearance of TBEV-spe-
cific immunoglobulin M (IgM) (acute-phase serum) was
available from 2 of 11 TBE patients. The patients, both 38
years of age, included a man from Vest-Agder County,
who had not been abroad during the last 4 weeks before
disease, and a woman from Hordaland County, who was
bitten by a tick on Bornholm Island. Both patients were
hospitalized with intensive headache. Results of clinical
and neurologic examinations were normal. Their leukocyte
counts in cerebrospinal fluid were 87–100/mm3. Both
patients recovered.
High levels of TBEV IgM and moderate to high levels
of TBEV IgG were detected in convalescent-phase sera
from both patients by enzyme immunoassay (Enzygnost,
Dade Behring, Marburg, Germany).
Ticks were collected by dragging a blanket in the field
in areas where patients with TBE had been reported. All
collected ticks were unfed. A total of 360 nymphs, adults,
and larvae were collected in May and June 2003, and 450
nymphs, adults, and larvae were collected from August 27
to October 8, 2004. Ticks were pooled according to collec-
tion site. All pools were stored at –70°C until preparation
of tick suspensions.
Acute-phase sera from the 2 patients and 810 ticks (I.
ricinus) were examined for TBEV. RNA was extracted
from serum samples and tick suspensions by using the
QIAamp Viral RNA Mini Kit (Qiagen, Germantown, MD,
USA) and the TriPure RNA isolation system (Roche
Diagnostics, Lewes, UK), respectively. For initial detec-
tion of TBEV RNA, the 5′ noncoding region was amplified
by nested RT-PCR (6), and positive samples were ampli-
fied in the coding E protein region (nucleotides [nt]
1323–1765). RT was performed by using MMLV
(Moloney murine leukemia virus) RT kit (Invitrogen,
Carlsbad, CA, USA) and reverse primer 827R (nt
1777–1800) (Table) according to manufacturer’s recom-
mendations. PCR and nested PCR were performed by
using primer pairs 283F1 (nt 1233–1255) to 827R1 (nt
1777–1800) and 349F2 (nt 1301–1322) to 814R2 (nt
1766–1787), respectively (Table). Additional details about
PCR assays are available from the corresponding author
upon request. PCR amplicons were purified and sequenced
by using a DNA sequencing kit (ABI Prism, PE
Biosystems, Foster City, CA, USA) on a 3100 genetic ana-
lyzer (PE Biosystems).
The Phylip program package (7) was used to analyze
the E protein gene sequence data: 500 bootstrap replicates
(Phylip’s SeqBoot Program) were fed to the Dnadist pro-
gram (with Kimura’s 2-parameter option), distance matrix-
es were analyzed with the Fitch program (which used the
Fitch-Margoliash algorithm), and the bootstrap support
values for the tree were calculated with the Consense
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From 360 ticks collected in 2003, only 1 pool (10 ticks)
was positive by amplification of the 5′ noncoding region;
similarly, only 1 pool of 450 ticks collected in 2004 was
RT-PCR-positive. From the positive tick pool in 2004, we
sequenced 179 nt of the highly conserved region in 5′
region of TBEV, enough to prove that the virus was TBEV,
not LIV. No material from the tick pools was left to attempt
virus isolation. Thus, the overall virus prevalence in ticks
was 0.3% in 2003 and 0.2% in 2004, if we assume that
only 1 tick in the positive pool was infected.
A partial E gene sequence (443 bp) was recovered from
the 2 human samples. The corresponding TBEV strains
were designated as Norway-1 and Denmark-1. The identity
on the nucleotide level between these sequences was
98.6%, and they showed 97.2%–99.0% identity to other
TBEV strains within the TBEV-Eu subtype. The levels of
sequence identity to strains belonging to TBEV-FE and
TBEV-Sib subtypes were 81.4%–83.0% and 83.5%–
86.2%, respectively. Phylogenetic analysis of these
sequences showed that they belong to the TBEV-Eu sub-
type (Figure), which does not show clear, separated lineag-
es correlating to geographic regions. The Norwegian TBEV
strain clustered together with strain Neudoerfl isolated in
Austria, and the Denmark-1 strain clustered together with
the group of strains from Latvia, Finland (Kumlinge), and
Estonia, albeit bootstrap supports of these clusterings were
below the widely accepted confidence limit, 70%. The
sequence identity between strains Denmark-1 and
Neudoerfl was 99.0%; between strains Norway-1 and
Latvia9783, the sequence identity was 98.7%.
Conclusions
This is the first report of TBEV RNA in serum from
Norwegian patients. One of the 2 patients was infected in
Vest-Agder County in Norway, and the other on Bornholm
Island, Denmark. Genetic analysis showed that the
Norwegian and Danish strains belong to the TBEV-Eu sub-
type. Although the sequences of Norway-1 and Denmark-
1 strains showed the highest level of identity to the
corresponding sequences of TBEV-Eu subtype, they were
distinguishable from each other and also from the
sequences of TBEV-Eu strains characterized previously.
In TBE-endemic areas in Europe and on Bornholm
Island, 0.5%–5% of ticks are infected with TBEV (5). In
Norway, where TBE is a rare disease, the prevalence is
lower (0.2%–0.3%). In Denmark TBEV has been detected
in ticks by RT-PCR (5), but to our knowledge, no reports
of TBEV findings in Danish patients exist.
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Figure. Consensus phylogenetic tree (Fitch-Margoliash) based on
the E protein encoding sequence (nucleotides 1323-1765). Only
bootstrap support values >70% are shown. Newly identified tick-
borne encephalitis virus (TBEV) strains from Norway and
Denmark are underlined. Abbreviations and accession numbers
for viruses and TBEV strains: Powassan virus, POWV, strain LB
(L06436); Langat virus, LGTV, strain TP21 (AF253419); Kyasanur
forest disease virus, KFDV, (X74111.1); Omsk hemorrhagic fever
virus, OHFV, (X66694.1); TBEV, strain IR991M4 (AB049349);
TBEV, strain IR992M3 (AB049350); TBEV, strain IR992M7
(AB049351); TBEV, strain IR992F7 (AB049352); TBEV, strain
IR992F13 (AB049353); TBEV, strain IR991M1 (AB049348); TBEV,
strain Aina (AF091006); TBEV, strain Vasilchenko (AF069066);
TBEV, strain Latvia 1-96 (AJ415565); TBEV, strain Oshima
(AB022292); TBEV, strain Sofjin (X03870.1); TBEV, strain KH98-
10 (AB022297); TBEV, strain Tblood (AF091019); TBEV, strain
RK1424 (AF091016); TBEV, strain N132 (AF091013); TBEV,
strain 263 (U27491); TBEV, strain Latvia-12718-00 (AJ319586);
TBEV, strain Hypr (U39292); TBEV, strain Neudoerfl (U27495);
TBEV, strain Latvia-9793-00 (AJ319585); TBEV, strain Latvia-
8110-00 (AJ319583); TBEV, strain Kumlinge-A52 (X60286); TBEV,
strain Latvia-8369-00 (AJ19584); TBEV, strain Latvia-11686-00
(AJ319582); TBEV, strain Lithuania-1-00 (AJ414703); louping Ill
virus (LIV), strain UK369/T2 (Y07863.1); LIV, strain Turkey
(LO1265); LIV, strain Greece (X77732); LIV, strain Spain
(X77470.1); LIV, strain Japan 3248/49/P10 (M94956.1).The emergence of TBE in Norway in the 1990s poses
the question of whether these new endemic foci have
become truly established recently or have remained unno-
ticed because of underdiagnosis. Although the northern
spread of TBEV due to climate changes has been predict-
ed (8), other factors such as rates of contact between ticks
and humans, abundance of ticks, and their amplifying
hosts may play a role in TBE epidemiology. Further mon-
itoring of the TBE situation in Norway both in patients and
nature is needed to establish guidelines for preventive
measures and vaccination programs in TBE-endemic
areas.
We report the first genome detection and characteriza-
tion of TBEV from persons with TBE in Norway and
Denmark. Our results showed that the Norwegian and
Danish strains clustered with earlier reported strains of the
TBEV-Eu subtype.
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malaria
Malaria, "bad air" in Italian, was blamed for the deaths of >1,000 workers digging the Erie Canal
in 1819. Work on the canal continued in winter, when the swamp was frozen over (and, although
the vector was not known at the time, mosquitoes were dormant). Malaria, caused by parasites of
the genus Plasmodium and usually transmitted by the bite of infected Anopheles mosquitoes, is
endemic in many warm regions. Charles Louis Alphonse Laveran discovered the protozoan cause
of malaria in 1880. The Office of Malaria Control in War Areas, which was established in 1942 to
control malaria and other vectorborne diseases in the southern United States, evolved into what is
today the Centers for Disease Control and Prevention.
Sources: Dorland's illustrated medical dictionary. 30th ed. Philadelphia: Saunders; 2003; cdc.gov; and wikipedia.org
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